All patients after any transplantation are on immunosupressive drugs, making them at higher risk for developing malignancies. Most common of these are lymphoproliferative disorders, designated as PTLD (Post-transplant lymphoproliferative disorders). Testicular cancers are rare after the age of 32 years though rare kinds, including lumphomas of testis, may occur later, and in renal transplant recipients.